bicalutamide and zm 252868

bicalutamide has been researched along with zm 252868 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrow, D; Dutkowski, CM; Goddard, L; Harper, ME; Jones, HE; Nicholson, RI; Smith, C	1

Other Studies

1 other study(ies) available for bicalutamide and zm 252868

Article	Year
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways. The Prostate, 2001, Sep-15, Volume: 49, Issue:1 Topics: Androgen Antagonists; Anilides; Blotting, Western; Cell Division; Drug Interactions; Enzyme Inhibitors; ErbB Receptors; Humans; Immunohistochemistry; Male; Nitriles; Prostatic Neoplasms; Quinazolines; Signal Transduction; Tosyl Compounds; Tumor Cells, Cultured	2001

Article

Year

Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.

The Prostate, 2001, Sep-15, Volume: 49, Issue:1

Topics: Androgen Antagonists; Anilides; Blotting, Western; Cell Division; Drug Interactions; Enzyme Inhibitors; ErbB Receptors; Humans; Immunohistochemistry; Male; Nitriles; Prostatic Neoplasms; Quinazolines; Signal Transduction; Tosyl Compounds; Tumor Cells, Cultured

2001